Advertisements

Азатиоприн

Quick links to important sections

Азатиоприн

Selected form

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Азатиоприн

Property Description
Active ingredient Azathioprine (Азатиоприн)
Form Tablets, Capsules, Powder for Injection
Pharmacological class Immunosuppressive Agent, Antimetabolite
General purpose Immune system modulation and suppression
Origin Synthetic (Purine Analog)

What Type of Medicine is Azathioprine?

Azathioprine is a critical, synthetic medication classified as a powerful immunosuppressive agent that belongs to the pharmacological subgroup of antimetabolites. It is clinically recognized for its ability to regulate the immune system in complex autoimmune disorders. Azathioprine is utilized to decrease or prevent the body's immune reaction, helping to manage conditions where the immune system is overly active. It functions as an inactive precursor, or prodrug, chemically related to mercaptopurine. The pharmacological difference lies in its specific purine analog structure, which provides a key differentiation from other immunosuppressive therapies by targeting the metabolic needs of rapidly dividing immune cells.

Composition and Available Forms of Azathioprine

The drug is manufactured as a single active ingredient product, with Azathioprine being the sole therapeutic chemical entity. Upon entering the body, Azathioprine is converted into its primary active metabolite, mercaptopurine, and subsequently into 6-thioguanine nucleotides, which are responsible for its therapeutic effect. This transformation allows the medication to function as a chemical precursor that becomes an effective therapeutic agent inside the body. For administration flexibility, the medication is available in several dosage forms, including common oral tablets and capsules, alongside a sterile powder for injection for intravenous use. This versatility allows medical professionals to select the optimal route of administration based on the patient's acute or chronic care needs.

What is the General Purpose of Azathioprine?

The overall general therapeutic purpose of Azathioprine is to provide sustained chronic immunosuppression by reducing the excessive or inappropriate activity of the body's immune system. Its systemic function limits the proliferation of lymphocytes—the T-cells and B-cells that drive inflammatory and destructive processes. By acting as an antimetabolite to suppress the replication of these aggressive immune cells, the medication offers the essential benefit of achieving long-term immune system control, a typical use scenario being the maintenance therapy required after an organ transplant.

Regulatory References

  1. MedlinePlus
Advertisements

What side effects are possible with Азатиоприн?

Possible Side Effects and Safety Information

The safety profile of Azathioprine is primarily defined by its immunosuppressive and cytotoxic effects on rapidly dividing cells, as documented in official regulatory sources. The adverse reactions are formally classified by frequency and system involvement.

Frequency-Classified Adverse Reactions

Classification Example Reactions (System-Organ Class)
Very Common Bone marrow depression (leukopenia), Nausea, Loss of appetite (Gastrointestinal, Hematologic)
Common Thrombocytopenia, Infections, Elevated liver enzymes, Hypersensitivity reactions (Multiple Systems)
Uncommon Anemia, Pancreatitis (Hematologic, Gastrointestinal)
Rare Severe liver damage (veno-occlusive disease), Malignancies, Pneumonitis (Hepatobiliary, Neoplastic, Respiratory)

Serious Safety Concerns and Restrictions

The regulatory label highlights several serious adverse reactions. The most significant are severe myelosuppression (life-threatening bone marrow suppression) and an increased risk of various malignancies, including lymphomas and skin cancers, which is associated with the long-term duration of immunosuppression.

Population-Specific Safety Notes exist, particularly concerning patients with inherited deficiencies of the TPMT or NUDT15 enzymes, who are at a significantly higher risk of severe, potentially life-threatening toxicity. Due to enhanced toxicity risk, the function of the kidneys and liver should be monitored closely in patients with existing renal or hepatic impairment. The medication is restricted for use in individuals with known hypersensitivity or those with active, severe infections.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Azathioprine states that overexposure primarily affects the hematologic system and may result in severe and life-threatening myelotoxicity (bone marrow suppression). The clinical signs of overdose, which can be delayed, include pancytopenia, severe leukopenia, fever, infections, ulceration of the throat, bruising, bleeding, and fatigue.

Documented Emergency Actions

Action Required (Regulatory Phrasing) Conditions Mandating Immediate Help
Seek immediate medical attention for suspected overdose. Collapse, seizure, trouble breathing, or inability to be awakened.
Call the poison control helpline for initial guidance. Any signs of acute overdose or severe toxicity.

Supportive Management and Risk Factors

The prescribing information confirms that no specific antidote is known for Azathioprine overdosage. Treatment is symptomatic and supportive, and dialysis may be used in severe cases as the drug is dialysable. Regulatory documents require that blood count and hepatic function be monitored. A specific risk is noted for patients with low or absent TPMT activity, who face a significantly increased risk of developing severe toxicity; additionally, a chronic minor overdose is considered more likely to cause toxicity than a single, large acute ingestion.

Advertisements

Therapeutic Uses of Азатиоприн

What Азатиоприн Treats: Main Uses and Benefits

Azathioprine is commonly used across conditions characterized by periods of heightened symptoms where long-term immune modulation is needed. Its primary use is in transplant medicine, supporting allograft survival following major procedures like kidney and liver transplantation. The medication is considered relevant in managing long-term immune system control.

The medicine is also relevant for easing the burden of chronic symptoms in severe autoimmune disorders. It is used for managing conditions such as severe, active Rheumatoid Arthritis, Inflammatory Bowel Disease (Crohn's disease and Ulcerative Colitis), and certain forms of Systemic Lupus Erythematosus. It helps address symptom clusters that create noticeable physiological strain, such as joint pain and swelling or severe gastrointestinal distress.

The therapeutic benefit often extends to its role as a steroid-sparing agent, which may assist with reducing reliance on high-dose corticosteroids while supporting general well-being during symptomatic phases. The medication is commonly used to help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Chronic Joint Pain and Systemic Inflammation

Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Status

Azathioprine is approved for use in adult and pediatric patients undergoing allogenic organ transplantation. It is also indicated for adults with severe, active Rheumatoid Arthritis not managed by conventional therapies. However, regulatory documents establish several absolute exclusions and conditional limitations.

Populations Who Must Not Use the Medicine

The medicine is contraindicated for patients with a known hypersensitivity to Azathioprine or its metabolite, 6-mercaptopurine. A critical exclusion is for individuals with low or absent activity of the enzyme TPMT (thiopurine methyltransferase) due to the risk of life-threatening toxicity. Additionally, it is explicitly contraindicated for treating Rheumatoid Arthritis in pregnant women.

Conditional and Restricted Use

Eligibility is conditional for patients with impaired renal or hepatic function, who require a substantial dose reduction to the lower end of the normal range. Geriatric patients also require reduced dosing. Breastfeeding is contraindicated, and concurrent use with live vaccines is prohibited. Adolescent and young adult males with Inflammatory Bowel Disease are identified as a population requiring caution due to a specific, documented malignancy risk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Azathioprine outlines several clinically significant interaction patterns primarily related to metabolic interference and pharmacodynamic effects.

Metabolic and Exposure Interactions

Co-administration with Allopurinol requires a mandatory dosage reduction of Azathioprine to twenty-five percent (25%) of the normal dose. This is due to Allopurinol’s inhibitory effect on the Xanthine Oxidase enzyme, which substantially increases the concentration of Azathioprine’s active metabolites, raising the risk of severe myelosuppression. The use of the related inhibitor, Febuxostat, is officially not recommended by regulatory agencies. Interaction risk is also heightened when Azathioprine is co-administered with Aminosalicylates (e.g., mesalazine) or Trimethoprim/Sulfamethoxazole, as these agents interfere with metabolic clearance, increasing the potential for toxicity.

Pharmacodynamic and Avoidance Restrictions

Azathioprine antagonises the effect of non-depolarising neuromuscular blocking agents (e.g., rocuronium) but potentiates the blockade produced by depolarising agents (e.g., suxamethonium). Due to the high risk of disseminated infection in an immunosuppressed state, co-administration with live vaccines is avoided. Other potent immunosuppressants are not recommended for combined use. A crucial population-specific constraint is noted for patients with low or absent activity of the TPMT or NUDT15 enzymes, who face a life-threatening risk of myelotoxicity at conventional doses. Additionally, for patients with Rheumatoid Arthritis, prior treatment with alkylating agents constitutes a contraindication due to malignancy risk.

Advertisements

Mechanism of Action

How Azathioprine Works

The action of Azathioprine is strictly dependent on its role as an antimetabolite prodrug, which disrupts the core processes essential for the replication of immune cells, resulting in a systemic decrease in immune cell activity and proliferation.


Prodrug Conversion and Metabolic Restriction

Azathioprine is metabolically converted into active compounds, primarily 6-thioguanine nucleotides (6-TGNs) and 6-methylmercaptopurine ribonucleotides (6-MMPNs). These metabolites act as false substrates, interfering with the purine de novo synthesis pathway by inhibiting key enzymes, thereby depriving rapidly dividing cells, especially T- and B-lymphocytes, of essential DNA building blocks.


Cytotoxic Action and Lymphocyte Depletion

The 6-TGNs are incorporated directly into the DNA and RNA of activated lymphocytes. This integration causes damage to the genetic code, leading to chromosomal breaks and the subsequent induction of programmed cell death (apoptosis). This mechanism results in a systemic reduction in the functional population of activated lymphocytes.


Mechanism Limitations and Genetic Sensitivity

The activity of the mechanism is not immediate, requiring time for metabolite accumulation and DNA incorporation, which necessitates a delay in the full expression of its mechanistic action. Furthermore, the mechanism is sensitive to the activity of the deactivating enzyme Thiopurine methyltransferase (TPMT); genetic variations can alter the metabolic balance, shifting it toward either excessive formation of active metabolites or increased formation of inactive metabolites.

Advertisements

Dosage and Administration Information

How to Use Azathioprine — Official Administration Guidelines

Azathioprine is administered through two officially approved methods: the oral route (tablets) for chronic, long-term therapy, and the intravenous (IV) route as a temporary measure for patients unable to tolerate the oral form. The IV form requires reconstitution of the powder for injection before infusion, and conversion to oral dosing should occur as soon as the patient's condition allows.

Official Dosing Regimens and Timing

Official dosing is weight-based (mg/kg) and administered once daily or in divided doses.

Indication Initial Dosing Schedule Maintenance Dosing Schedule
Renal Transplant 3 to 5 mg/kg daily 1 to 3 mg/kg daily
Rheumatoid Arthritis Approximately 1.0 mg/kg daily; Maximum dose is 2.5 mg/kg daily Lowest effective dose; Dose adjusted in approximately 0.5 mg/kg increments at 4-week intervals

Administration Requirements and Adjustments

Administration includes several specific, labeled instructions. Oral tablets must be swallowed whole and should not be split or crushed. Although tablets may be taken with or after food to help mitigate gastrointestinal effects, patients should standardize the timing of their intake.

Crucially, azathioprine must not be taken with milk or dairy products; a separation of at least 1 hour before or 2 hours after consuming dairy is mandated to prevent potential reduction in absorption. Dosage adjustments, typically to the lower end of the normal range, are required for older adults and for patients with renal or hepatic impairment. Furthermore, dose modification or alternative therapy is required for patients with documented TPMT or NUDT15 genetic deficiencies.

Advertisements

Recent Clinical Evidence

Azathioprine: Recent Clinical Evidence

Azathioprine is an immunosuppressive drug studied extensively in the treatment of autoimmune diseases and in organ transplantation. Evidence from clinical trials and meta-analyses supports its role across several chronic conditions.


Evidence in Inflammatory Bowel Disease (IBD)

Multiple controlled trials and cohort studies support the use of azathioprine for maintaining remission in Crohn's disease (CD), particularly in patients who are steroid-dependent. A Cochrane review noted that studies indicate a benefit for maintaining remission in CD compared to placebo.

In Ulcerative Colitis (UC), evidence suggests that azathioprine may be useful for inducing and maintaining remission in patients who have not responded adequately to other first-line therapies. Studies have also explored the appropriate duration of therapy, suggesting that discontinuation may be considered for CD patients in stable, long-term remission, though relapse rates can vary.


Evidence in Rheumatoid Arthritis (RA) and Transplantation

As a disease-modifying anti-rheumatic drug (DMARD), older trials suggest azathioprine may contribute to a reduction in tender joint scores in patients with active rheumatoid arthritis when compared to placebo. However, this evidence is often based on limited and older data.

In organ transplantation, azathioprine is a foundational component of immunosuppressive regimens, often used in combination with other agents to prevent acute graft rejection. Although newer agents like mycophenolate mofetil have shown greater efficacy in preventing early acute rejection in some trials, azathioprine remains a viable option in some protocols, particularly in kidney transplantation.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Азатиоприн (FAQ)

Q: Is Азатиоприн considered a chemotherapy drug?

A: Azathioprine is formally classified as an immunosuppressive agent and an antimetabolite prodrug, according to official product information. Although the antimetabolite class is shared with some chemotherapy treatments, Azathioprine's regulatory-approved function is to modulate the immune system.

Q: Is there a generic version of Азатиоприн available?

A: Yes, regulatory approval records confirm that the patent for Azathioprine has expired. This means the medicine is widely available as a generic version, manufactured by various companies.

Q: Is it normal to feel tired when first starting Азатиоприн?

A: Official safety information indicates that unusual tiredness can occur as a side effect. This may be a signal that the medicine is affecting your white blood cell count, which is why regular monitoring is typically required during treatment.

Q: What are the most common reasons someone might have to stop taking Азатиоприн?

A: According to official warnings, treatment may need to be stopped if serious side effects develop. The most significant reasons involve signs of severe bone marrow suppression, such as dangerously low blood cell counts, or other severe issues like liver problems, pancreatitis, or serious allergic reactions.

Q: What kind of blood tests are necessary while taking Азатиоприн?

A: Official instructions mandate laboratory monitoring. Periodic monitoring of your complete blood counts (CBC), which check blood cell levels, as well as liver function tests (LFTs) is typically required to ensure the medication is not causing toxicity.

Q: How often are blood tests typically required when starting this medicine?

A: The frequency of monitoring is initially very close, as outlined in official administration instructions. Blood tests are typically required weekly during the first month of treatment. The frequency is then gradually reduced over the following months if the treatment remains stable.

Q: Does sun exposure need to be limited when taking Азатиоприн?

A: Yes, official warnings indicate that Azathioprine can increase your skin’s sensitivity to sunlight (photosensitivity). To mitigate this increased risk, regulatory agencies advise limiting sun exposure and using protective measures like clothing and sunscreen.

Q: Are there any non-prescription supplements or vitamins that interact with Азатиоприн?

A: Official guidance from regulatory bodies advises caution regarding non-prescription supplements and herbal remedies. There is not enough comprehensive data available to definitively confirm the safety of taking these products alongside Azathioprine.

Q: What happens if I miss a dose of Азатиоприн?

A: Patient information leaflets typically contain specific instructions regarding missed doses, which outline the steps to follow if a scheduled dose is forgotten. Never take two doses at once to make up for a missed dose.

Q: Can I drink coffee or tea while taking Азатиоприн?

A: Official guidance strongly mandates avoiding the consumption of milk or dairy products within a two-hour window of taking the medication. While coffee and tea are not strictly prohibited, some patient resources suggest avoiding coffee if you experience stomach irritation, as this is a known side effect of the medicine.

Q: What should I do if I experience nausea or stomach upset on Азатиоприн?

A: Nausea and stomach upset are listed as very common side effects in the official safety profile. The product information suggests that this gastrointestinal irritation can often be mitigated by consistently taking the medicine with food.

Q: Does Азатиоприн cause hair loss?

A: Hair loss, medically known as alopecia, has been reported as a side effect in official safety documentation. It is generally listed as a less common occurrence associated with the use of this medication.

Q: How long can a person safely stay on Азатиоприн for a chronic condition?

A: Azathioprine is designed for sustained, chronic immunosuppression in long-term conditions. However, regulatory documents highlight that the duration of use is subject to careful monitoring due to the increased risk of certain malignancies associated with long-term immune suppression.

Q: Does Азатиоприн interact with common over-the-counter pain relievers?

A: Interactions with common pain relievers vary. For example, regulatory interaction resources usually show no major conflict with acetaminophen. However, regulatory documents indicate caution may be necessary for some nonsteroidal anti-inflammatory drugs (NSAIDs).

Q: What are the signs of a serious infection I should watch for while on this medication?

A: Official patient instructions advise vigilance for signs of infection, as the medicine suppresses the immune system. These signs include symptoms like fever, chills, persistent cough, hoarseness, and painful or difficult urination.

Q: Is Азатиоприн safe to use alongside biologics like adalimumab?

A: Studies and clinical documents indicate that Azathioprine is frequently used in combination therapy, such as with biologic medicines like adalimumab. This combination is often utilized in treating conditions like inflammatory bowel disease to help improve the overall effectiveness of the treatment plan.

Q: Does Азатиоприн interact with alcohol consumption?

A: Official patient information indicates that alcohol does not typically interfere with how Azathioprine works. However, since the medication can affect liver function, regulatory sources advise limiting alcohol intake to reduce the cumulative risk of liver damage.

Q: What is the typical timeframe for a doctor to decide if Азатиоприн is working?

A: Because Azathioprine is a prodrug that requires time for metabolic conversion and cell incorporation, the full therapeutic effect is not immediate. Studies and patient information suggest that it typically requires several months, such as three to six months, before the medicine’s full clinical benefit can be assessed.

Q: Are there any specific genetic tests (like TPMT) required before starting Азатиоприн?

A: Official regulatory warnings strongly recommend genetic testing for the TPMT and NUDT15 enzymes before or at the start of therapy. This testing helps identify individuals who are at a significantly higher risk of life-threatening toxicity with conventional dosing.

Q: Does Азатиоприн interact with herbal remedies, such as St. John's wort?

A: Regulatory agencies advise caution because these products are often not rigorously tested for interactions with prescription medicines. There is limited information to confirm the safety of using Azathioprine with many herbal remedies.

Q: What are the signs that my body is rejecting Азатиоприн?

A: The official safety profile lists hypersensitivity reactions as a potential side effect. Signs of a serious reaction may include a rash, fever, chills, dizziness, vomiting, or muscle pain, and such symptoms are typically addressed by healthcare providers immediately.

Q: How soon after stopping Азатиоприн does the immune system return to normal?

A: While the drug itself has a short half-life and is rapidly metabolized, its suppressive effects on immune cell populations can persist. Regulatory pharmacokinetic data indicates the return to normal immune function may take a longer, variable period after stopping the medication.

Q: What is the purpose of using Азатиоприн in combination with a corticosteroid?

A: In clinical practice and documented studies, Azathioprine is often combined with a corticosteroid to achieve a steroid-sparing effect. This approach allows the dosage of the corticosteroid to be gradually lowered or even discontinued while maintaining the treatment's desired effect.

Q: Is there a specific time of day when Азатиоприн should be taken?

A: Official administration guidance emphasizes the importance of taking the medicine at the same time every day. This consistency helps ensure a steady level of the drug is maintained in the bloodstream, though the label does not mandate a specific time (morning or evening) for intake.

Advertisements

How should Азатиоприн be stored and disposed of?

How to Store and Dispose of Azathioprine

Azathioprine tablets must be stored at controlled room temperature (20 C to 25 C) and protected from environmental factors. Keep the medication in the original container, tightly closed, and in a location protected from excess heat, moisture, and light. Storage should be away from the bathroom, and the product must be kept from freezing.

It is mandatory to store Azathioprine out of the sight and reach of children and to always use the locked safety cap. For the intravenous formulation, the reconstituted solution is stable for 24 hours at room temperature.

Disposal must be handled according to specific safety rules. Do not keep outdated or unused medicine; instead, ask a healthcare professional or pharmacist about drug take-back programs. Azathioprine is considered a cytotoxic drug in some documentation, which requires careful handling to avoid dust and disposal in accordance with all applicable local regulations for hazardous or specialized waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Азатиоприн found in:

A-Z Index: